Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_assertion type Assertion NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_head.
- NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_provenance.
- NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_assertion evidence source_evidence_literature NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_provenance.
- NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_assertion SIO_000772 21258814 NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_provenance.
- NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_assertion wasDerivedFrom befree-20150227 NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_provenance.
- NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_assertion wasGeneratedBy ECO_0000203 NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_provenance.